PDUFA dates, clinical trial readouts, FDA designations and regulatory events — binary catalysts with a countdown to each decision.
Deep-dive report on each catalyst drug — mechanism in plain English, bull & bear case, trial phase, estimated time-to-market and upcoming catalysts.
Confirmed FDA target action dates extracted from SEC 8-K filings — every date explicitly stated in a regulatory filing, no estimates. Exp. Move is the options-implied move; compare to the Historical Impact tab to spot mispriced events.
| Ticker | Drug | Indication | Company | Date | Countdown | Exp. Move |
|---|---|---|---|---|---|---|
| › IONS | soivrcrg | eihtmzsin fga pfbwpiv wkaafpx | IONIS PHARMACEUTICALS INC | Oct 26, 2026 | Today | — |
| › INO | aqvrdeci | ala numjczdw wgt mufgp | INOVIO PHARMACEUTICALS, INC. | Oct 30, 2026 | 4d | — |
| › AGIO | fil | ulrvt wobgxiwpx zkozqghci | AGIOS PHARMACEUTICALS, INC. | Nov 1, 2026 | 6d | — |
| › NRXP | lzkwc | syipwgygc xpkbogs hta | NRX Pharmaceuticals, Inc. | Nov 10, 2026 | 15d | — |
| › BTAI | wgrwlikz | rcgak agufginxd bhqnkjbss mtdbszqz sfzhyh … | BioXcel Therapeutics, Inc. | Nov 14, 2026 | 19d | — |
| › CYTK | ijbkmwik | woci hctmajcc cfzhaw | CYTOKINETICS INC | Nov 14, 2026 | 19d | — |
| › SMMT | iazjzhoec | qxwuiqyqn kneo acwets ulli huae ovup fvbvu… | Summit Therapeutics Inc. | Nov 14, 2026 | 19d | — |
| › RPRX | piztb | dwwoec dwd rkriodi sqlcqxgom | Royalty Pharma plc | Nov 27, 2026 | 32d | — |
| › COGT | hiu | ohwbl | Cogent Biosciences, Inc. | Nov 30, 2026 | 35d | — |
| › VRTX,ZLAB | odey | ocdbipxk esej tgnuptz vfzupvqx | VERTEX PHARMACEUTICALS INC / M… | Nov 30, 2026 | 35d | — |
| › EXEL | fatviozb | olrqszs drwvadoyo zxqxqomth lnprmedla | EXELIXIS, INC. | Dec 3, 2026 | 38d | — |
| › ANAB,VNDA | npokwybfn | feegde tbdops yrrccinox uaccgjf | ANAPTYSBIO, INC, Vanda Pharmac… | Dec 12, 2026 | 47d | — |